
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Novotech and PPC Group have announced that they have formed a strategic partnership to meet growing demand for clinical trials in the Asia-Pacific region. Under the partnership, the companies will share an integrated governance structure as well as aligned systems and processes.
To get more information, click






